{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:48Z","timestamp":1786119648847,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/olq.0b013e31820b8bb4","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T03:17:04Z","timestamp":1297394224000},"page":"299-305","source":"Crossref","is-referenced-by-count":27,"title":["Poor Provider Adherence to the Centers for Disease Control and Prevention Treatment Guidelines in US Emergency Department Visits With a Diagnosis of Pelvic Inflammatory Disease"],"prefix":"10.1097","volume":"38","author":[{"given":"Ting-Yu","family":"Shih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A.","family":"Gaydos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsiang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"RR-6","key":"R2-10-20210213","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention.","volume":"51","year":"2002","journal-title":"MMWR Recomm Rep"},{"issue":"RR-5","key":"R3-10-20210213","first-page":"1","article-title":"Pelvic inflammatory disease: Guidelines for prevention and management.","volume":"40","year":"1991","journal-title":"MMWR Recomm Rep"},{"issue":"RR-14","key":"R4-10-20210213","first-page":"1","article-title":"1993 sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention.","volume":"42","year":"1993","journal-title":"MMWR Recomm Rep"},{"issue":"RR-1","key":"R5-10-20210213","first-page":"1","article-title":"1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention.","volume":"47","year":"1998","journal-title":"MMWR Recomm Rep"},{"issue":"RR-11","key":"R6-10-20210213","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines 2006. Centers for Disease Control and Prevention.","volume":"55","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R7-10-20210213","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00007435-199603000-00012","article-title":"Management of pelvic inflammatory disease by primary care physicians. A comparison with Centers for Disease Control and Prevention guidelines.","volume":"23","author":"Hessol","year":"1996","journal-title":"Sex Transm Dis"},{"key":"R8-10-20210213","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0002-9378(11)90790-X","article-title":"Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility.","volume":"168","author":"Hillis","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"R9-10-20210213","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1001\/jama.1988.03720120027030","article-title":"Risk factors for ectopic pregnancy. A population-based study.","volume":"259","author":"Marchbanks","year":"1988","journal-title":"JAMA"},{"key":"R10-10-20210213","article-title":"Healthy people 2000: National health promotion and disease prevention objectives. Full report with commentary. Department of Health and Human Services publication PHS 91\u201360212.","year":"1991"},{"key":"R12-10-20210213","first-page":"1007","article-title":"Visits to emergency departments for gynecologic disorders in the United States, 1992\u20131994.","volume":"91","author":"Curtis","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R13-10-20210213","first-page":"1","article-title":"Ambulatory medical care utilization estimates for 2006.","volume":"8","author":"Schappert","year":"2008","journal-title":"Natl Health Stat Report"},{"key":"R14-10-20210213","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1553-2712.2004.tb01455.x","article-title":"Compliance with the Centers for Disease Control and Prevention recommendations for the diagnosis and treatment of sexually transmitted diseases.","volume":"11","author":"Kane","year":"2004","journal-title":"Acad Emerg Med"},{"key":"R15-10-20210213","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.annemergmed.2003.10.034","article-title":"Emergency department management of sexually transmitted infections in US adolescents: Results from the National Hospital Ambulatory Medical Care Survey.","volume":"43","author":"Beckmann","year":"2004","journal-title":"Ann Emerg Med"},{"key":"R17-10-20210213","first-page":"1","article-title":"National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary.","volume":"386","author":"Nawar","year":"2007","journal-title":"Adv Data"},{"key":"R18-10-20210213","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/01.olq.0000175375.60973.cb","article-title":"Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985\u20132001.","volume":"32","author":"Sutton","year":"2005","journal-title":"Sex Transm Dis"},{"key":"R20-10-20210213","doi-asserted-by":"crossref","first-page":"e8945","DOI":"10.1371\/journal.pone.0008945","article-title":"Antiviral prescriptions to U.S. ambulatory care visits with a diagnosis of influenza before and after high level of adamantane resistance 2005\u201306 season.","volume":"5","author":"Hsieh","year":"2010","journal-title":"PLoS One"},{"key":"R21-10-20210213","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1197\/j.aem.2005.09.015","article-title":"Embedded guideline information without patient specificity in a commercial emergency department computerized order-entry system.","volume":"13","author":"Asaro","year":"2006","journal-title":"Acad Emerg Med"},{"key":"R22-10-20210213","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1197\/jamia.M1656","article-title":"Integrating \u201cbest of care\u201d protocols into clinicians' workflow via care provider order entry: Impact on quality-of-care indicators for acute myocardial infarction.","volume":"13","author":"Ozdas","year":"2006","journal-title":"J Am Med Inform Assoc"},{"key":"R23-10-20210213","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1001\/jama.286.20.2578","article-title":"Improving the quality of medical care: Building bridges among professional pride, payer profit, and patient satisfaction.","volume":"286","author":"Grol","year":"2001","journal-title":"JAMA"},{"key":"R24-10-20210213","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1478-4505-3-4","article-title":"Current and future developments in managed care in the United States and implications for Europe.","volume":"3","author":"Lagoe","year":"2005","journal-title":"Health Res Policy Syst"},{"issue":"suppl 2","key":"R25-10-20210213","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1378\/chest.118.2_suppl.40S","article-title":"Organizational interventions to encourage guideline implementation.","volume":"118","author":"Curry","year":"2000","journal-title":"Chest"},{"key":"R26-10-20210213","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2217\/17455057.4.4.383","article-title":"Diagnosis and treatment of pelvic inflammatory disease.","volume":"4","author":"Haggerty","year":"2008","journal-title":"Womens Health (Lond Engl)"},{"key":"R27-10-20210213","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/147323000303100108","article-title":"Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease.","volume":"31","author":"Bevan","year":"2003","journal-title":"J Int Med Res"},{"key":"R28-10-20210213","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.AOG.0000268801.90261.27","article-title":"Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: A randomized controlled trial.","volume":"110","author":"Savaris","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R29-10-20210213","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1086\/512191","article-title":"Newest approaches to treatment of pelvic inflammatory disease: A review of recent randomized clinical trials.","volume":"44","author":"Haggerty","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R30-10-20210213","first-page":"834","article-title":"Tips from other journals: Azithromycin vs. doxycycline for the treatment of PID.","volume":"77","author":"Walling","year":"2008","journal-title":"Am Fam Physician"},{"issue":"suppl 1","key":"R31-10-20210213","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1086\/514720","article-title":"Anaerobes in pelvic inflammatory disease: Implications for the Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases.","volume":"28","author":"Walker","year":"1999","journal-title":"Clin Infect Dis"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007435-201104000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:49:35Z","timestamp":1786042175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007435-201104000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e31820b8bb4","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}